Acadian Asset Management LLC Hutchmed (China) LTD Transaction History
Acadian Asset Management LLC
- $48.4 Billion
- Q2 2025
A detailed history of Acadian Asset Management LLC transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Acadian Asset Management LLC holds 31,078 shares of HCM stock, worth $476,736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,078
Previous 7,723
302.41%
Holding current value
$476,736
Previous $116,000
301.72%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HCM
# of Institutions
61Shares Held
6.13MCall Options Held
0Put Options Held
0-
Schroder Investment Management Group London, X02.58MShares$39.6 Million0.03% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M925KShares$14.2 Million0.02% of portfolio
-
State Street Corp Boston, MA329KShares$5.04 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.84 Million0.11% of portfolio
-
Goldman Sachs Group Inc New York, NY289KShares$4.44 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.65B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...